Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Vitamin C vs Niacinamide for Melasma
NCT07890571Not yet recruiting
- Sponsor
- Pak Emirates Military Hospital
- Start
- Nov 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Randomised trial in melasma comparing Topical 10 % vitamin C GROUP with Topical 10% niacinamide group (2 arms). Primary endpoint: Melasma Area and Severity Index at 12 weeks. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
ascorbic acidnicotinamide
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07890571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07890571.